Cryogenx Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Investors
-
11
Cryogenx General Information
Description
Manufacturer of a portable medical cooling device intended to treat heat-related illness and protect people from extreme heat exposure. The company offers a deployable core body cooling device that overcomes logistical and performance limitations of existing treatment methods, enabling healthcare providers, emergency responders, and heat-exposed workers to deliver timely heatstroke care and reduce the risk of death and injury.
Contact Information
Website
www.cryogenx.comCorporate Office
- Unit 12, Spectrum House
- 32-34 Gordon House Road
- London NW5 1LP
- England, United Kingdom
Corporate Office
- Unit 12, Spectrum House
- 32-34 Gordon House Road
- London NW5 1LP
- England, United Kingdom
Cryogenx Timeline
Cryogenx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 13-Jan-2026 | In Progress | Clinical Trials - General | |||
| 7. Later Stage VC | 15-Jul-2025 | Completed | Clinical Trials - General | |||
| 6. Accelerator/Incubator | 19-Sep-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 28-May-2021 | Completed | Product Development | |||
| 2. Grant | 01-Nov-2020 | $184K | Completed | Product Development | ||
| 1. Accelerator/Incubator | Completed | Startup |
Cryogenx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 7,268 | $0.000014 | $45.69 | $45.69 | 1x | $45.69 | 2.93% | |
| Ordinary | 47,577 | $0.000014 | $12.14 | $12.14 | 1x | $12.14 | 19.18% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cryogenx Signals
Cryogenx Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| British Design Fund | Venture Capital | Minority | ||
| Future Planet Capital | Venture Capital | Minority | ||
| Tailwind Futures | Venture Capital | Minority | ||
| UK Innovation & Science Seed Fund | Venture Capital | Minority | ||
| WilkinsonFuture | Corporate Venture Capital | Minority |
Cryogenx FAQs
-
When was Cryogenx founded?
Cryogenx was founded in 2019.
-
Where is Cryogenx headquartered?
Cryogenx is headquartered in London, United Kingdom.
-
What is the size of Cryogenx?
Cryogenx has 7 total employees.
-
What industry is Cryogenx in?
Cryogenx’s primary industry is Therapeutic Devices.
-
Is Cryogenx a private or public company?
Cryogenx is a Private company.
-
What is Cryogenx’s current revenue?
The current revenue for Cryogenx is .
-
How much funding has Cryogenx raised over time?
Cryogenx has raised $2.8M.
-
Who are Cryogenx’s investors?
British Design Fund, Future Planet Capital, Tailwind Futures, UK Innovation & Science Seed Fund, and WilkinsonFuture are 5 of 11 investors who have invested in Cryogenx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process